Tenaya Therapeutics Inc (TNYA)
4.62
+0.06
(+1.32%)
USD |
NASDAQ |
May 07, 16:00
4.62
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Net Income (TTM): -124.08M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -124.08M |
September 30, 2023 | -127.66M |
June 30, 2023 | -129.22M |
March 31, 2023 | -124.35M |
December 31, 2022 | -123.66M |
September 30, 2022 | -116.30M |
June 30, 2022 | -103.87M |
Date | Value |
---|---|
March 31, 2022 | -90.68M |
December 31, 2021 | -72.72M |
September 30, 2021 | -56.89M |
June 30, 2021 | -48.92M |
March 31, 2021 | -42.44M |
December 31, 2020 | -38.40M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-129.22M
Minimum
Jun 2023
-38.40M
Maximum
Dec 2020
-92.25M
Average
-103.87M
Median
Jun 2022
Net Income (TTM) Benchmarks
Adverum Biotechnologies Inc | -117.16M |
Solid Biosciences Inc | -96.02M |
Dyne Therapeutics Inc | -257.40M |
Sana Biotechnology Inc | -283.26M |
Prime Medicine Inc | -198.13M |